Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (2503)	9/16/2010 1:16:29 PM
From: ewolf	Respond to of 3027

Teva is a major phama. They say they have confidence in getting approval soon. That's enough to make people believe the story. Of course, Mnta said they were confident of gaining approval for a very long time, so it's not illogical to back mnta stock, but it is relatively riskier.

To: tom pope who wrote (2503)	9/16/2010 1:40:08 PM
From: Jeffry K. Smith	Read Replies (1) \| Respond to of 3027

"The information I don't have, and would love to get my hands on, is that which is motivating a determined bunch of sellers... Are they misguided sheep or do they have information we don't have?" I don't get the impression that the iHub posters have information we don't have, and because of it are selling, or are nervous holders. Quite the contrary - I think that most of the people there are just as mystified as you as to why MNTA is not higher than it is, given the considerable positive information that has been posted about MNTA's prospects.